We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600012:SSEAnhui Expressway Company Limited Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥16.83

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Anhui Expressway is trading above its short‑, medium‑ and long‑term moving averages, with a bullish MACD crossover and momentum indicators firmly in the upper range, suggesting continued upward pressure. The stock has broken through recent resistance near the high of the day and is supported by a solid price floor just above the identified support zone, while trading volume has been on an upward trend, reinforcing the technical strength. The relative strength index sits well above the mid‑point, indicating robust buying interest but also a cautionary note of potential short‑term overextension. On the valuation side, the price‑to‑earnings multiple is markedly below the industry average and a discounted cash‑flow model points to a price considerably lower than intrinsic value, flagging a clear undervaluation. Dividend yield is among the higher tier for its sector, with a payout ratio comfortably below the half‑way mark, supporting the view that cash returns are sustainable. Fundamentally, the firm maintains healthy gross and operating margins, and generates strong operating cash flow that more than covers its free cash outlays. However, revenue has contracted sharply year‑over‑year, and the balance sheet carries a high leverage ratio, which tempers the upside. Despite the debt load, the company holds ample cash reserves, mitigating immediate solvency concerns. The beta is exceptionally low, indicating that the stock’s price moves largely independent of broader market swings, while recent volatility has been moderate. Overall, the blend of technical momentum, attractive dividend profile, and significant valuation discount makes the stock compelling, albeit with caution due to earnings decline and leverage.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance after a bullish breakout
  • RSI approaching overbought territory
  • Increasing volume confirming momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial valuation discount to peers and DCF estimate
  • Strong dividend yield with sustainable payout
  • Low beta and stable cash flow supporting defensive profile

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term infrastructure demand in China
  • Consistently high operating margins despite revenue dip
  • Undervalued price relative to earnings and industry multiples

Key Metrics & Analysis

Financial Health

Revenue Growth-44.20%
Profit Margin34.03%
P/E Ratio15.3
ROE13.20%
ROA5.75%
Debt/Equity97.90
P/B Ratio2.2
Op. Cash FlowCN¥3.4B
Free Cash FlowCN¥1.1B
Industry P/E30.0

Technical Analysis

TrendBullish
RSI66.4
SupportCN¥15.41
ResistanceCN¥16.85
MA 20CN¥15.99
MA 50CN¥15.67
MA 200CN¥14.93
MACDBullish
VolumeIncreasing
Fear & Greed Index93.13

Valuation

Fair ValueCN¥1.94
GradeUndervalued
TypeValue
Dividend Yield3.67%

Risk Assessment

Beta0.12
Volatility23.43%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.